Common digestive side effects include: Nausea (affecting up to 44% of patients in clinical trials) Diarrhoea (approximately 30% of patients) Constipation (around 24% of patients) Vomiting (reported by roughly 24% of patients) Abdominal pain, bloating, and dyspepsia Gastro-oesophageal reflux symptoms These effects are typically most pronounced during dose escalation and often improve as the body adapts to the medication
For a 40-unit semaglutide dose, the 0.5 mL syringe provides the best combination of capacity and readability
Table of Contents: What BMI qualifies for Semaglutide GLP-1 treatment
Its important to avoid using other GLP-1 receptor agonists concomitantly and to consult with a healthcare provider regarding the safe use of Wegovy alongside other prescriptions, especially insulin, sulfonylureas, and medications that affect gastric motility
"2024 Employer Health Benefits Survey"
The adoption tax credit shall help clear the costs associated with adoption and recommend families to offer loving homes to children in need of adoption